184 related articles for article (PubMed ID: 28655527)
1. Changes in Adenosine Triphosphate and Nitric Oxide in the Urothelium of Patients with Benign Prostatic Hyperplasia and Detrusor Underactivity.
Cho KJ; Koh JS; Choi J; Kim JC
J Urol; 2017 Dec; 198(6):1392-1396. PubMed ID: 28655527
[TBL] [Abstract][Full Text] [Related]
2. Urothelial Barrier Deficits, Suburothelial Inflammation and Altered Sensory Protein Expression in Detrusor Underactivity.
Jiang YH; Kuo HC
J Urol; 2017 Jan; 197(1):197-203. PubMed ID: 27436428
[TBL] [Abstract][Full Text] [Related]
3. Correlation Between Nitric Oxide and Urodynamics in Men With Bladder Outlet Obstruction.
Cho KJ; Koh JS; Choi JB; Park SH; Lee WS; Kim JC
Int Neurourol J; 2022 Feb; 26(Suppl 1):S15-21. PubMed ID: 33957714
[TBL] [Abstract][Full Text] [Related]
4. Activation of P2Y6 Receptors Facilitates Nonneuronal Adenosine Triphosphate and Acetylcholine Release from Urothelium with the Lamina Propria of Men with Bladder Outlet Obstruction.
Silva I; Ferreirinha F; Magalhães-Cardoso MT; Silva-Ramos M; Correia-de-Sá P
J Urol; 2015 Oct; 194(4):1146-54. PubMed ID: 26004864
[TBL] [Abstract][Full Text] [Related]
5. Clinical characteristics and useful signs to differentiate detrusor underactivity from bladder outlet obstruction in men with non-neurogenic lower urinary tract symptoms.
Matsukawa Y; Yoshida M; Yamaguchi O; Takai S; Majima T; Funahashi Y; Yono M; Sekido N; Gotoh M
Int J Urol; 2020 Jan; 27(1):47-52. PubMed ID: 31542892
[TBL] [Abstract][Full Text] [Related]
6. Does detrusor underactivity affect the results of transurethral resection of prostate?
Abdelhakim MA; Rammah A; Abozamel AH; El-Sheikh MG; Abdelazeem MS; Abdallah SM; Abdelaziz AY
Int Urol Nephrol; 2021 Feb; 53(2):199-204. PubMed ID: 33074461
[TBL] [Abstract][Full Text] [Related]
7. Effect of Preoperative Urodynamic Detrusor Underactivity on Transurethral Surgery for Benign Prostatic Hyperplasia: A Systematic Review and Meta-Analysis.
Kim M; Jeong CW; Oh SJ
J Urol; 2018 Jan; 199(1):237-244. PubMed ID: 28760632
[TBL] [Abstract][Full Text] [Related]
8. Detrusor underactivity in men with lower urinary tract symptoms/benign prostatic obstruction: characterization and potential impact on indications for surgical treatment of the prostate.
Rademakers KL; van Koeveringe GA; Oelke M
Curr Opin Urol; 2016 Jan; 26(1):3-10. PubMed ID: 26574876
[TBL] [Abstract][Full Text] [Related]
9. Unravelling detrusor underactivity: Development of a bladder outlet resistance-Bladder contractility nomogram for adult male patients with lower urinary tract symptoms.
Oelke M; Rademakers KL; van Koeveringe GA;
Neurourol Urodyn; 2016 Nov; 35(8):980-986. PubMed ID: 26235823
[TBL] [Abstract][Full Text] [Related]
10. Detrusor underactivity influences the efficacy of TURP in patients with BPO.
Zhu Y; Zhao YR; Zhong P; Qiao BM; Yang ZQ; Niu YJ
Int Urol Nephrol; 2021 May; 53(5):835-841. PubMed ID: 33386583
[TBL] [Abstract][Full Text] [Related]
11. Effects of tadalafil versus silodosin on voiding function in male patients with non-neurogenic detrusor underactivity: A comparative study using propensity score matching.
Matsukawa Y; Majima T; Funahashi Y; Fujita T; Ishida S; Kato M; Gotoh M
Int J Urol; 2021 Apr; 28(4):411-416. PubMed ID: 33393153
[TBL] [Abstract][Full Text] [Related]
12. Impact of detrusor underactivity on the postoperative outcomes after benign prostatic enlargement surgery.
Plata M; Santander J; Trujillo CG; Bravo-Balado A; Robledo D; Higuera T; Caicedo JI
Neurourol Urodyn; 2021 Mar; 40(3):868-875. PubMed ID: 33645847
[TBL] [Abstract][Full Text] [Related]
13. Detrusor underactivity in pelvic organ prolapse.
Frigerio M; Manodoro S; Cola A; Palmieri S; Spelzini F; Milani R
Int Urogynecol J; 2018 Aug; 29(8):1111-1116. PubMed ID: 29270721
[TBL] [Abstract][Full Text] [Related]
14. The role of clean intermittent catheterization in the treatment for detrusor underactivity.
Méndez-Rubio S; López-Pérez E; Laso-Martín S; Vírseda-Chamorro M; Salinas-Casado J; Esteban-Fuertes M; Moreno-Sierra J
Actas Urol Esp (Engl Ed); 2020 May; 44(4):233-238. PubMed ID: 32151472
[TBL] [Abstract][Full Text] [Related]
15. A Prediction Model of Detrusor Underactivity Based on Symptoms and Noninvasive Test Parameters in Men with Lower Urinary Tract Symptoms: An Analysis of a Large Group of Patients undergoing Pressure-Flow Studies.
Namitome R; Takei M; Takahashi R; Kikutake C; Yokomizo A; Yamaguchi O; Eto M
J Urol; 2020 Apr; 203(4):779-785. PubMed ID: 31647388
[TBL] [Abstract][Full Text] [Related]
16. The role of bladder wall thickness in the evaluation of detrusor underactivity: Development of a clinical nomogram.
De Nunzio C; Lombardo R; Cicione A; Trucchi A; Carter S; Tema G; Nacchia A; Vicentini C; Tubaro A
Neurourol Urodyn; 2020 Apr; 39(4):1115-1123. PubMed ID: 32110842
[TBL] [Abstract][Full Text] [Related]
17. Expression of 5-Hydroxytryptamine Receptors in Human Urinary Bladders with Benign Prostatic Hyperplasia.
Imamura T; Ishizuka O; Ogawa T; Minagawa T; Ishikawa M; Hiragata S; Yokoyama H; Nakazawa M; Kurizaki Y; Nishizawa O
Adv Ther; 2015 Oct; 32 Suppl 1():29-37. PubMed ID: 26391373
[TBL] [Abstract][Full Text] [Related]
18. Urinary adenosine triphosphate and nitric oxide levels in patients with underactive bladder: a preliminary study.
Krishnan A; Sharma G; Devana SK; Zohmangaihi D; Mavuduru RS; Mandal AK; Sharma AP; Bora GS
World J Urol; 2021 Dec; 39(12):4421-4425. PubMed ID: 34406435
[TBL] [Abstract][Full Text] [Related]
19. Predictives regarding outcome after transurethral resection for prostatic adenoma associated with detrusor underactivity.
Seki N; Kai N; Seguchi H; Takei M; Yamaguchi A; Naito S
Urology; 2006 Feb; 67(2):306-10. PubMed ID: 16461081
[TBL] [Abstract][Full Text] [Related]
20. Urodynamic effects of once daily tadalafil in men with lower urinary tract symptoms secondary to clinical benign prostatic hyperplasia: a randomized, placebo controlled 12-week clinical trial.
Dmochowski R; Roehrborn C; Klise S; Xu L; Kaminetsky J; Kraus S
J Urol; 2010 Mar; 183(3):1092-7. PubMed ID: 20092847
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
